Gene: TP53

Basic information

Tag Content
Uniprot ID P04637; Q15086; Q15087; Q15088; Q16535; Q16807; Q16808; Q16809; Q16810; Q16811; Q16848; Q2XN98; Q3LRW1; Q3LRW2; Q3LRW3; Q3LRW4; Q3LRW5; Q86UG1; Q8J016; Q99659; Q9BTM4; Q9HAQ8; Q9NP68; Q9NPJ2; Q9NZD0; Q9UBI2; Q9UQ61;
Entrez ID 7157
Genbank protein ID AAF36356.1; CAA42630.1; ABA29757.1; AAF63442.1; AAA61212.1; CAA42627.1; AAF36358.1; AAF36379.1; CAA42635.1; AAF36359.1; AAK76359.1; CAA26306.1; AAA59987.1; AAA59989.1; AAF36362.1; CAA42626.1; ABA29756.1; ABB80266.1; AAR10356.1; AAF36377.1; AAK76358.1; CAA42632.1; CAA42634.1; AAF36355.1; BAG35463.1; ABA29754.1; CAA42631.1; AAC12971.1; AAF36376.1; AAF36360.1; EAW90144.1; CAA42633.1; CAA42629.1; AAF36378.1; AAQ90158.1; AAA59988.1; AAF36357.1; AAD28628.1; AAF36381.1; AAP30003.1; CAA38095.1; AAF36375.1; BAC16799.1; AAF63443.1; AAF36374.1; AAF36354.1; ABA29755.1; AAG28785.1; CAA25652.1; AAR13239.1; AAB39322.1; AAH03596.1; AAF36361.1; EAW90143.1; AAF36382.1; CAA42628.1; AAD28535.1; AAA61211.1; ABB80262.1; AAF36380.1; AAV80424.1; ABA29753.1;
Genbank nucleotide ID NM_001126116.1; NM_001276697.1; NM_001276761.1; NM_001126112.2; NM_001276699.1; NM_001126118.1; NM_001276695.1; NM_001276698.1; NM_001276760.1; NM_001126114.2; NM_001126113.2; NM_000546.5; NM_001126117.1; NM_001126115.1; NM_001276696.1;
Ensembl protein ID ENSP00000481638; ENSP00000480868; ENSP00000482222; ENSP00000478219; ENSP00000482258; ENSP00000484409; ENSP00000391478; ENSP00000391127; ENSP00000481179; ENSP00000482537; ENSP00000398846; ENSP00000269305; ENSP00000478499;
Ensembl nucleotide ID ENSG00000141510
Gene name Cellular tumor antigen p53
Gene symbol TP53
Organism Homo sapiens
NCBI taxa ID 9606
Cleft type
Developmental stage
Data sources Homology search
Reference
Functional description Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
Sequence
MEEPQSDPSV EPPLSQETFS DLWKLLPENN VLSPLPSQAM DDLMLSPDDI EQWFTEDPGP 60
DEAPRMPEAA PPVAPAPAAP TPAAPAPAPS WPLSSSVPSQ KTYQGSYGFR LGFLHSGTAK 120
SVTCTYSPAL NKMFCQLAKT CPVQLWVDST PPPGTRVRAM AIYKQSQHMT EVVRRCPHHE 180
RCSDSDGLAP PQHLIRVEGN LRVEYLDDRN TFRHSVVVPY EPPEVGSDCT TIHYNYMCNS 240
SCMGGMNRRP ILTIITLEDS SGNLLGRNSF EVRVCACPGR DRRTEEENLR KKGEPHHELP 300
PGSTKRALPN NTSSSPQPKK KPLDGEYFTL QIRGRERFEM FRELNEALEL KDAQAGKEPG 360
GSRAHSSHLK SKKGQSTSRH KKLMFKTEGP DSD 393

Abbreviation :
CLO : cleft lip only. CPO : cleft palate only. CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.

Gene expression information

Gene expression in different tissues (GTEx V7)

  

Gene expression in different tissues (ENCODE)

  

Protein structural annotations

3D structure in PDB database


Protein disorder information

Orthologous information

Other genetic variants/mutations

Disease or phenotype associated information

Gene Ontology (GO)/biological pathways

GO:Molecular Function


GO:Biological Process


GO:Cellular Component


Reactome Pathway

Drugs and compounds information

Functional annotations

Keywords

Interpro

PROSITE

Pfam

Protein-protein interaction

Protein-miRNA interaction